This message was sent to ##Email##
|
|
|
|
|
By Jason Poquette
 As Donald Trump assumes the role of president, there may be no bigger issue on the minds of Americans than the question of how he will tackle the rising cost of healthcare. We have heard the campaign slogan related to the Affordable Care Act, that he will "repeal and replace" it. But few seem to know what exactly that will mean. Retail and community pharmacists like myself are curious about how the new administration will impact the real-life practice of pharmacy.
READ MORE
AzPA
Pharmacy Day at the Capitol is right around the corner! It is being held Wednesday, Feb. 1 on the Senate Lawn at the State Capitol. This is your opportunity to meet with legislators and educate them on the important role that Pharmacists play in the healthcare field and in the community every single day. We will also be utilizing this time to talk to legislators about some of the limitations and unfair practices Pharmacists experience, which AzPA is working to improve through legislation this year. If you are interested in volunteering and having your voice heard, please fill out the survey here and someone from our office will contact you as soon as possible. We appreciate your commitment to improving pharmacy practice in the state of Arizona!
AzPA
This certificate program is a comprehensive program designed to provide pharmacists with the basic knowledge and skills necessary to care for patients taking anticoagulation therapies. By completing this course, pharmacists can earn 22 contact hours of continuing pharmacy education credit while becoming certified in anticoagulation management. Click here to register for the Jan. 21, 2017, program in Glendale.
AzPA
Registration is now open for the 50th Southwestern Clinical Pharmacy Seminar. You can earn up to 10 CPE credits (1.0 CEUs) at this two day event, Feb. 25-26, 2017, in Tucson. To view the conference agenda and hotel information, click here.
For registration information, click here.
AzPA Monthly Virtual Learning Webinar Series
Jan. 31, 2017
Click here for more information
Pharmacy Day at the Capitol (PD@C)
Feb. 1, 2017
Phoenix, Arizona
AzPA Anticoagulation Certificate Program
Feb. 24, 2017 — Tucson, Arizona
June 8, 2017 — Tucson, Arizona
AzPA Immunization Certificate Program
Feb. 24, 2017 — Tucson, Arizona
April 4, 2017 — Glendale, Arizona
April 28, 2017 — Phoenix, Arizona
June 8, 2017 — Tucson, Arizona
Southwest Clinical Pharmacy Seminar
Feb. 25-26, 2017
Tucson, Arizona
APhA Diabetes Certificate Program
Feb. 26, 2017
The Westin La Paloma
Tucson, Arizona
APhA Pharmacy-Based Cardiovascular Disease Risk Management
April 28, 2017
Phoenix, Arizona
Psychiatric Certificate Program
June 8, 2017
Tucson, Arizona
2017 Annual Convention
June 9-11, 2017
The Westin La Paloma
Tucson, Arizona
2017 Southwestern States Residency Conference
June 9, 2017
The Westin La Paloma
Tucson, Arizona
2017 Fall Conference
Sept. 9, 2017
Phoenix, Arizona
APhA Delivering Medication Therapy Management Certificate Program
Sept. 10, 2017
Phoenix, Arizona
Ruhr-University Bochum via ScienceDaily
The multiple sclerosis therapy alemtuzumab can trigger severe, unpredictable side effects. Scientists report on two patients for whom the infusion of alemtuzumab significantly worsened symptoms. The team also describes a treatment that successfully curbed the harmful side effects.
READ MORE
Pharmacy Practice News
The FDA has approved Vantrela extended-release tablets with Teva’s proprietary abuse deterrence technology targeting oral, intranasal and IV routes. Vantrela ER is indicated to manage pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate.
READ MORE
APhA
Following on the heels of the provider status bill that was reintroduced in the Senate on Jan. 12, members of the U.S House of Representatives swiftly reintroduced the Pharmacy and Medically Underserved Areas Enhancement Act with a total of 107 original cosponsors.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
Pharmacy TImes
The FDA is allowing the sale of EU-approved Panretin gel tubes in the United States due to a shortage of the U.S.-approved gel as a result of a manufacturing issue, officials with Eisai announced in a press release that was shared on the FDA’s website.
READ MORE
Pharmacy Practice News
Nearly two years after approving the nation’s first biosimilar, the FDA released its draft guidance recommending how sponsors of proposed therapeutic proteins can demonstrate interchangeability with reference products when applying for marketing approval.
READ MORE
The New York Times
In his first executive order, President Donald Trump directed government agencies to scale back as many aspects of the Affordable Care Act as possible, moving within hours of being sworn in to fulfill his pledge to eviscerate Barack Obama’s signature health care law.
READ MORE
Pharmacy Times
The FDA has accepted the new drug application for EZR-201, an investigational product from Ezra Innovations for the treatment of hypertension and heart failure. EZR-201 combines an angiotensin receptor blocker, valsartan, with Rubireten delivery technology.
READ MORE
|
|
|
50 Minthorn Blvd.Suite 800, Thornhill, Ontario L3T 7X8
|
